Form EFFECT Scinai Immunotherapeutic
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 28, 2026 |
| Accession Number: | 0001213900-26-094234 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AlphaStaffHCM Launches Human Capital Management Solutions for Faster Hiring, Reduced Turnover, and Smarter Decisions
- Chengwei Semiconductor Launches Laboratory Gas Pipeline System and Laboratory Gas Scrubber for High-Purity Specialty Gases
- Closing of strategic transaction to create a leading Nordic IPP
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
